Autogenous Injectable Bone for Regeneration with Mesenchymal Stem Cells and Platelet-Rich Plasma: Tissue-Engineered Bone Regeneration
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
We have attempted to regenerate bone in a significant osseous defect with minimal invasiveness and good plasticity, and to provide a clinical alternative to autogenous bone grafts. Platelet-rich plasma (PRP) may enhance the formation of new bone and is nontoxic, nonimmunoreactive, and accelerates existing wound-healing pathways. We have used a combination of PRP as an autologous scaffold with in vitro-expanded mesenchymal stem cells (MSCs) to increase osteogenesis, compared with using the scaffold alone or autogenous particulate cancellous bone and marrow (PCBM). The newly formed bones were evaluated by radiography, histology, and histomorphometric analysis in the defects at 2, 4, and 8 weeks. According to the histological observations, the dog MSCs (dMSCs)/PRP group had well-formed mature bone and neovascularization compared with the control (defect only), PRP, and PCBM groups at 2 and 4 weeks. Histometrically, at 8 weeks newly formed bone areas were 18.3 +/- 4.84% (control), 29.2 +/- 5.47% (PRP), 61.4 +/- 3.38% (PCBM), and 67.3 +/- 2.06% (dMSCs/PRP). There were significant differences between the PCBM, dMSCs/PRP, and control groups. These results demonstrate that the dMSCs/PRP mixture is useful as a osteogenic bone substitute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
Marx, R. E., Carlson, E. R., Eichstaedt, R. M., Schimmele, S. R., Strauss, J. E., & Georgeff, K. R. (1998) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/s1079-2104(98)90029-4 · Cited by 2,598
Bruder, S. P., Jaiswal, N., & Haynesworth, S. E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f · Cited by 1,485
Tissue-engineered bone regeneration
Petite, H., Viateau, V., Bensaïd, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., & Guillemin, G. (2000) · Nature Biotechnology · doi:10.1038/79449 · Cited by 1,475
Characterization of cells with osteogenic potential from human marrow
Haynesworth, S. E., Goshima, J., Goldberg, V. M., & Caplan, A. I. (1992) · Bone · doi:10.1016/8756-3282(92)90364-3 · Cited by 1,289
Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells
Bruder, S. P., Kurth, A. A., Shea, M., Hayes, W. C., Jaiswal, N., & Kadiyala, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160202 · Cited by 761
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755
Selective cell transplantation using bioabsorbable artificial polymers as matrices
Vacanti, J. P., Morse, M. A., Saltzman, W. M., Domb, A. J., Perez-Atayde, A., & Langer, R. (1988) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(88)80529-3 · Cited by 602
Kadiyala, S. (1997) · Cell Transplantation · doi:10.1016/s0963-6897(96)00279-5 · Cited by 588
Kadiyala, S., Jaiswal, N., & Bruder, S. P. (1997) · Tissue Engineering · doi:10.1089/ten.1997.3.173 · Cited by 255
Yamada, Y., Seong Boo, J., Ozawa, R., Nagasaka, T., Okazaki, Y., Hata, K.-I., & Ueda, M. (2003) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/s1010-5182(02)00143-9 · Cited by 249
Self-citationBowen‐Pope, D. F., VOGEL, A. M., & Ross, R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2396 · Cited by 227
Hill, P. A. (1998) · British Journal of Orthodontics · doi:10.1093/ortho/25.2.101 · Cited by 206
Beyond Transplantation: Third Annual Samuel Jason Mixter Lecture
Vacanti, J. P. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400290027003 · Cited by 177
Tissue-Engineered Bone Using Mesenchymal Stem Cells and a Biodegradable Scaffold
Boo, J. S., Yamada, Y., Okazaki, Y., Hibino, Y., Okada, K., Hata, K., Yoshikawa, T., Sugiura, Y., & Ueda, M. (2002) · Journal of Craniofacial Surgery · doi:10.1097/00001665-200203000-00009 · Cited by 138
Self-citationDynamics of neovascularization in normal tissue
Zawicki, D. F., Jain, R. K., Schmid-Schöenbein, G. W., & Chien, S. (1981) · Microvascular Research · doi:10.1016/0026-2862(81)90003-0 · Cited by 96
Mundy, G. R., Rodan, S. B., Majeska, R. J., DeMartino, S. A., Trimmier, C., Martin, T. J., & Rodan, G. A. (1982) · Calcified Tissue International · doi:10.1007/bf02411301 · Cited by 40
Cited by
Dohan Ehrenfest, D. M., Rasmusson, L., & Albrektsson, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.11.009 · Cited by 2,008
Dohan, D. M., Choukroun, J., Diss, A., Dohan, S. L., Dohan, A. J. J., Mouhyi, J., & Gogly, B. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2005.07.008 · Cited by 1,861
Platelet-Rich Plasma: From Basic Science to Clinical Applications
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009) · The American Journal of Sports Medicine · doi:10.1177/0363546509349921 · Cited by 1,323
Kim, J., Li, W. A., Choi, Y., Lewin, S. A., Verbeke, C. S., Dranoff, G., & Mooney, D. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3071 · Cited by 541
New insights into and novel applications for platelet-rich fibrin therapies
Anitua, E., Sánchez, M., Nurden, A. T., Nurden, P., Orive, G., & Andía, I. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2006.02.010 · Cited by 527
Metadata
- Authors
- Yamada, Y., Ueda, M., Naiki, T., Takahashi, M., Hata, K.-I., & Nagasaka, T.
- Venue
- Tissue Engineering
- Publisher
- SAGE Publications
- Published
- 2004-05
- Volume
- 10
- Issue
- 5-6
- Pages
- 955-964
- ISSN
- 1076-3279 (ISSN-L)
- 1557-8690
- OpenAlex
- W2020832712
- Cited by
- 309
- References
- 18
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.